HIV-Associated Lymphomas: Progress and New Challenges

The association of human immunodeficiency virus (HIV) and aggressive lymphomas was first reported in 1982. Before the development of effective HIV antiviral therapy, the incidence and the mortality of these lymphomas was high, with patients frequently succumbing to the disease. More lately, the comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Pongas, Georgios N., Ramos, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911067/
https://www.ncbi.nlm.nih.gov/pubmed/35268547
http://dx.doi.org/10.3390/jcm11051447
_version_ 1784666685991550976
author Pongas, Georgios N.
Ramos, Juan C.
author_facet Pongas, Georgios N.
Ramos, Juan C.
author_sort Pongas, Georgios N.
collection PubMed
description The association of human immunodeficiency virus (HIV) and aggressive lymphomas was first reported in 1982. Before the development of effective HIV antiviral therapy, the incidence and the mortality of these lymphomas was high, with patients frequently succumbing to the disease. More lately, the combination of cART with chemoimmunotherapy significantly improved the survival outcome of the HIV-lymphomas. In this review, we discuss on describing the incidence of HIV-associated lymphomas, their clinical features, and the latest advances in the management of the various lymphoma subtypes.
format Online
Article
Text
id pubmed-8911067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89110672022-03-11 HIV-Associated Lymphomas: Progress and New Challenges Pongas, Georgios N. Ramos, Juan C. J Clin Med Review The association of human immunodeficiency virus (HIV) and aggressive lymphomas was first reported in 1982. Before the development of effective HIV antiviral therapy, the incidence and the mortality of these lymphomas was high, with patients frequently succumbing to the disease. More lately, the combination of cART with chemoimmunotherapy significantly improved the survival outcome of the HIV-lymphomas. In this review, we discuss on describing the incidence of HIV-associated lymphomas, their clinical features, and the latest advances in the management of the various lymphoma subtypes. MDPI 2022-03-07 /pmc/articles/PMC8911067/ /pubmed/35268547 http://dx.doi.org/10.3390/jcm11051447 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pongas, Georgios N.
Ramos, Juan C.
HIV-Associated Lymphomas: Progress and New Challenges
title HIV-Associated Lymphomas: Progress and New Challenges
title_full HIV-Associated Lymphomas: Progress and New Challenges
title_fullStr HIV-Associated Lymphomas: Progress and New Challenges
title_full_unstemmed HIV-Associated Lymphomas: Progress and New Challenges
title_short HIV-Associated Lymphomas: Progress and New Challenges
title_sort hiv-associated lymphomas: progress and new challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911067/
https://www.ncbi.nlm.nih.gov/pubmed/35268547
http://dx.doi.org/10.3390/jcm11051447
work_keys_str_mv AT pongasgeorgiosn hivassociatedlymphomasprogressandnewchallenges
AT ramosjuanc hivassociatedlymphomasprogressandnewchallenges

Ejemplares similares